CTRI/2021/05/033803招募中未知
Comparison of chemotherapy combined with percutaneous electroporation and chemotherapy alone in the management of locally advanced carcinoma of the gall bladder
SERB0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with unresectable malignant GB masses
- •2. Life expectancy of at least 3 months.
- •3. Size of tumor < 6 cm in largest dimension.
- •4. Total bilirubin level < 2.5 mg/dl
排除标准
- •1. Uncorrectable coagulopathy
- •2. Patients with poor general condition and estimated life expectancy less than 3
- •3. Patients unfit for general anaesthesia
- •4. Presence of cardiac disease/arrhythmia/heart block
- •5. Presence of malignant ascites
- •6. Presence of metastatic disease
研究者
相似试验
未知
1 期
Clinical evaluation of NK211 and CDDP for cervical cancer.Advanced and/or recurrent cervical cancer.JPRN-jRCT2080221794ippon Kayaku Co., Ltd.
招募中
2 期
Phase II study of combination chemotherapy using paclitaxel, carboplatin, and bevacizumab in patients with advanced or recurrent cervical cancer.cervical cancerJPRN-UMIN000024137Hyogo Cancer Center30
已完成
1 期
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40
已完成
3 期
A phase III randomized study with Paclitaxel (Taxol) and Gemcitabine or Vinorelbine in patients with stage IIIBw - IV non-operable non-small cell lung cancer (NSCLC), performance status (PS) 0,1.Non-Small Cell Lung CancerACTRN12609000946213Hellenic Cooperative Oncology Group441
招募中
2 期
Phase II Study of combination chemotherapy with SPT in patient with HER2(+) advanced gastric cancerJPRN-UMIN000011595Kawasaki Gastric Cancer Group(KGCG)15